Last reviewed · How we verify
NCT05898529
COVID Infection in Pediatric Surgical Patient
trial testing Rapid antigen test in COVID-19 in 350 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Salem Anaesthesia Pain Clinic |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 350 |
| Start date | 1 July 2023 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Rapid antigen test
Conditions studied
- COVID-19 — all drugs for COVID-19 →
Sponsor
Salem Anaesthesia Pain Clinic
Who can join
Adults 2 to 17, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Children infected with COVID-19 are mostly asymptomatic. There is a dearth of data on the epidemiology of COVID-19 in the pediatric population. This is a prospective observational clinical study of pediatric surgical patients. COVID-19 rapid antigen testing will be performed on pediatric patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05898529
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Salem Anaesthesia Pain Clinic trials
Trials by the same sponsor.
- NCT05618002 — Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients · recruiting
- NCT05277038 — Clonidine is Better Than Zopiclone for Insomnia Treatment in Chronic Pain Patients · completed
- NCT06802562 — Medical Assistance in Dying Requests in Pain Clinic · completed
- NCT05950243 — COVID-19 Disease & Vaccine Survey in Africa · completed
- NCT05876117 — Premedication for Claustrophobic Patients for MRI Scan · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05898529 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Salem Anaesthesia Pain Clinic
- Last refreshed: 27 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05898529.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing